The DOI matches its Crossref record; 129 of the 134 references it cites were found in a registry or an index.
PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up
Open accessAbstract
Nanomedicines based on poly(lactic-co-glycolic acid) (PLGA) carriers offer tremendous opportunities for biomedical research. Although several PLGA-based systems have already been approved by both the Food and Drug Administration (FDA) and the European Medicine Agency (EMA), and are widely used in the clinics for the treatment or diagnosis of diseases, no PLGA nanomedicine formulation is currently available on the global market. One of the most impeding barriers is the development of a manufacturing technique that allows for the transfer of nanomedicine production from the laboratory to an industrial scale with proper characterization and quality control methods. This review provides a comprehensive overview of the technologies currently available for the manufacturing and analysis of polymeric nanomedicines based on PLGA nanoparticles, the scale-up challenges that hinder their industrial applicability, and the issues associated with their successful translation into clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Challenges arise when moving from benchtop to large-scale production because, unlike the conventional drug products, the efficacy and safety, as well as the unique drug delivery characteristics of each individual nanomedicine formulation, are a direct consequence of the physicochemical properties of the nanoparticles that carry the drug, which can be altered when adopting a larger scale production”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [154]
In the citing paper
“Several PLGA-based systems have already been approved by both the FDA and the European Medicines Agency (EMA) and are widely used in clinics for the treatment or diagnosis of diseases, no PLGA nanomedicine formulation is currently available on the global market.154,155”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [154]
Citations
Cites
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodríguez-Torres, M. D. P., Acosta‐Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 7,085
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,755
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Nanoparticles in the clinic: an update
Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,731
An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering
Gentile, P., Chiono, V., Carmagnola, I., & Hatton, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033640 · Cited by 1,593
Properties of lactic acid based polymers and their correlation with composition
Södergård, A., & Stolt, M. (2002) · Progress in Polymer Science · doi:10.1016/s0079-6700(02)00012-6 · Cited by 1,461
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,361
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Hrkach, J. S., Hoff, D. D. V., Ali, M. M., Andrianova, E. A., Auer, J., Campbell, T., Witt, D. D., Figa, M. A., Figueiredo, M., Horhota, A. T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,170
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,089
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. S. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,001
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 986
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Adamo, A., Beingessner, R. L., Behnam, M., Chen, J., Jamison, T. F., Jensen, K. F., Monbaliu, J. M., Myerson, A. S., Revalor, E., Snead, D. R., et al. (2016) · Science · doi:10.1126/science.aaf1337 · Cited by 946
Block copolymer micelles for drug delivery: Design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.013 · Cited by 804
Nanomedicine: Principles, Properties, and Regulatory Issues
Soares, S., Sousa, J., Pais, A. A. C. C., & Vitorino, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00360 · Cited by 795
Synthesis and characterization of PLGA nanoparticles
Astete, C. E., & Sabliov, C. M. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206775997322 · Cited by 782
Convery, N., & Gadegaard, N. (2019) · Micro and Nano Engineering · doi:10.1016/j.mne.2019.01.003 · Cited by 643
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 626
Biju, V., Itoh, T., Anas, A., Sujith, A., & Ishikawa, M. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2185-7 · Cited by 586
Polymeric Conjugates for Drug Delivery
Larson, N., & Ghandehari, H. (2012) · Chemistry of Materials · doi:10.1021/cm2031569 · Cited by 580
Nanomedicines: addressing the scientific and regulatory gap
Tinkle, S. S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y., Tamarkin, L., & Desai, N. P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 552
A Perspective on Continuous Flow Chemistry in the Pharmaceutical Industry
Baumann, M., Moody, T. S., Smyth, M., & Wharry, S. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00524 · Cited by 514
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Kumar, M. N. V. R., Bakowsky, U., & Lehr, C. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 499
Nanoparticles in modern medicine: state of the art and future challenges.
(2007) · PubMed Central · Cited by 484
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 468
Application of Various Types of Liposomes in Drug Delivery Systems
Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466
Nanomedicine scale-up technologies: feasibilities and challenges
Paliwal, R., Babu, R. J., & Palakurthi, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0177-9 · Cited by 466
Principles of nanoparticle formation by flash nanoprecipitation
Saad, W., & Prud’homme, R. K. (2016) · Nano Today · doi:10.1016/j.nantod.2016.04.006 · Cited by 412
Challenges in nanomedicine clinical translation
Metselaar, J. M., & Lammers, T. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00740-5 · Cited by 405
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Véronique Préat, A., Langer, R., & Anderson, D. G. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 396
Han, F. Y., Thurecht, K. J., Whittaker, A. K., & Smith, M. T. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00185 · Cited by 375
Hernández-Giottonini, K. Y., Rodríguez-Córdova, R. J., Gutiérrez-Valenzuela, C. A., Peñuñuri-Miranda, O., Zavala‐Rivera, P., Guerrero‐Germán, P., & Lucero‐Acuña, A. (2020) · RSC Advances · doi:10.1039/c9ra10857b · Cited by 354
Continuous downstream processing of biopharmaceuticals
Jungbauer, A. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.05.011 · Cited by 329
Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions
Cole, K. P., Groh, J. M., Johnson, M. D., Burcham, C. L., Campbell, B. M., Diseroad, W. D., Heller, M. R., Howell, J. R., Kallman, N. J., Koenig, T. M., et al. (2017) · Science · doi:10.1126/science.aan0745 · Cited by 299
Lim, J., Swami, A., Gilson, L., Chopra, S., Choi, S., Wu, J., Langer, R., Karnik, R., & Farokhzad, O. C. (2014) · ACS Nano · doi:10.1021/nn501371n · Cited by 298
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities
Agrahari, V., & Agrahari, V. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.047 · Cited by 276
Werner, M. E., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D. T., & Wang, A. Z. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.02.009 · Cited by 267
Challenges in design of translational nanocarriers
Sun, Q., Radosz, M., & Shen, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.042 · Cited by 266
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
McCall, R. L., & Sirianni, R. W. (2013) · Journal of Visualized Experiments · doi:10.3791/51015 · Cited by 260
Wang, Y., Li, P., Tran, T. T. D., Zhang, J., & Kong, L. (2016) · Nanomaterials · doi:10.3390/nano6020026 · Cited by 258
Liu, D., Cito, S., Zhang, Y., Wang, C., Sikanen, T. M., & Santos, H. A. (2015) · Advanced Materials · doi:10.1002/adma.201405408 · Cited by 251
Cun, D., Jensen, D. K., Maltesen, M. J., Bunker, M., Whiteside, P. T., Scurr, D. J., Foged, C., & Nielsen, H. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.008 · Cited by 236
Becker, G., & Wurm, F. R. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00531a · Cited by 229
Merkel, T. J., Herlihy, K. P., Nunes, J. K., Orgel, R. M., Rolland, J. P., & DeSimone, J. M. (2009) · Langmuir · doi:10.1021/la903890h · Cited by 229
Injectable controlled release depots for large molecules
Schwendeman, S. P., Shah, R. B., Bailey, B. A., & Schwendeman, A. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.057 · Cited by 223
Sun, L., Liu, Z., Wang, L., Cun, D., Tong, H. H. Y., Yan, R., Chen, X., Wang, R., & Zheng, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.385 · Cited by 216
Grand challenges in nanomedicine
Wu, L., Wang, D., & Li, Z. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110302 · Cited by 210
Huang, W. C., & Zhang, C. (2017) · Biotechnology Journal · doi:10.1002/biot.201700203 · Cited by 206
Pharmaceutical Applications of Electrospraying
Nguyen, D. N., Clasen, C., & den Mooter, G. V. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.04.024 · Cited by 203
Drug-loaded polymeric nanoparticles: a review
de Castro, K. C., Costa, J. M., & Campos, M. G. N. (2020) · International Journal of Polymeric Materials · doi:10.1080/00914037.2020.1798436 · Cited by 178
Microfluidic assisted synthesis of PLGA drug delivery systems
Rezvantalab, S., & Moraveji, M. K. (2019) · RSC Advances · doi:10.1039/c8ra08972h · Cited by 171
Zweers, M. L. T., Engbers, G. H. M., Grijpma, D. W., & Feijén, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.008 · Cited by 162
Freitas, S., Hielscher, G., Merkle, H. P., & Gander, B. A. (2004) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2004.10.004 · Cited by 162
Khayata, N., Abdelwahed, W., Chehna, M. F., Charcosset, C., & Fessi, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.016 · Cited by 157
Namjoshi, S., Dabbaghi, M., Roberts, M. S., Grice, J. E., & Mohammed, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030287 · Cited by 153
Investigation of factors influencing the hydrolytic degradation of single PLGA microparticles
Keles, H., Naylor, A., Clegg, F., & Sammon, C. (2015) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2015.04.025 · Cited by 153
Nanomedicines: from bench to bedside and beyond.
Havel, H., Finch, G., Strode, P., Wolfgang, M., Zale, S., Bobe, I., Youssoufian, H., Peterson, M., & Liu, M. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9961-7 · Cited by 149
Agrahari, V., & Hiremath, P. S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0039 · Cited by 142
Transforming nanomedicine manufacturing toward Quality by Design and microfluidics
Colombo, S., Beck‐Broichsitter, M., Boetker, J. P., Malmsten, M., Rantanen, J., & Bohr, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.004 · Cited by 141
Feng, Q., Wu, J., Li, H., & Ma, G. (2018) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-018-1729-4 · Cited by 141
Issues and concerns in nanotech product development and its commercialization
Kaur, I. P., Kakkar, V., Deol, P. K., Yadav, M., Singh, M., & Sharma, I. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.005 · Cited by 128
Continuous Processing for Production of Biopharmaceuticals
Rathore, A. S., Agarwal, H., Sharma, A. K., Pathak, M., & Muthukumar, S. (2015) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2014.985834 · Cited by 128
Dong, Y., & Feng, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.031 · Cited by 126
Dalwadi, G., Benson, H. A. E., & Chen, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7781-z · Cited by 125
Spray Freeze-Drying as a Solution to Continuous Manufacturing of Pharmaceutical Products in Bulk
Adali, M. B., Barresi, A., Boccardo, G., & Pisano, R. (2020) · Processes · doi:10.3390/pr8060709 · Cited by 125
Kim, K.-T., Lee, J., Kim, D., Yoon, I., & Cho, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060280 · Cited by 118
Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products
Beg, S., Rahman, M., & Kohli, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.12.002 · Cited by 118
Bowerman, C. J., Byrne, J. D., Chu, K. S., Schorzman, A. N., Keeler, A. W., Sherwood, C. A., Perry, J. L., Luft, J. C., Darr, D. B., Deal, A. M., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b03971 · Cited by 113
Ghaderi, R., Artursson, P., & Carlfors, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018868423309 · Cited by 111
Myerson, A. S., Krumme, M., Nasr, M. M., Thomas, H., & Braatz, R. D. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24311 · Cited by 107
Bozdag, S., Dillen, K., Vandervoort, J., & Ludwig, A. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357056145 · Cited by 104
McWilliams, J. C., Allian, A. D., Opalka, S. M., May, S. A., Journet, M., & Braden, T. M. (2018) · Organic Process Research & Development · doi:10.1021/acs.oprd.8b00160 · Cited by 103
Poly(hydroxyalkanoates)‐Based Polymeric Nanoparticles for Drug Delivery
Errico, C., Bartoli, C., Chiellini, E., & Chiellini, E. (2009) · BioMed Research International · doi:10.1155/2009/571702 · Cited by 100
Kluge, J., Fusaro, F., Casas, N., Mazzotti, M., & Muhrer, G. (2009) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2009.05.010 · Cited by 99
Cationic Poly(lactide-co-glycolide) Nanoparticles as Efficient in vivo Gene Transfection Agents
Kumar, M. N. V. R., Mohapatra, S. S., Kong, X., Jena, P. K., Bakowsky, U., & Lehr, C. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.130 · Cited by 94
Influence of process conditions on the mean size of PLGA nanoparticles
Feczkó, T., Tóth, J. S., Dósa, G., & Gyenis, J. (2011) · Chemical Engineering and Processing - Process Intensification · doi:10.1016/j.cep.2011.05.006 · Cited by 94
Magnetic enhancement of iron oxide nanoparticles encapsulated with poly(d,l-latide-co-glycolide)
Lee, S.-J., Jeong, J., Shin, S., Kim, J., Chang, Y.-H., Lee, K., & Kim, J.-D. (2005) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2004.12.019 · Cited by 94
Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielińska, A., Ventura, F. V., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Nanomaterials · doi:10.3390/nano10030455 · Cited by 87
Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality
Landesman‐Milo, D., & Peer, D. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00607 · Cited by 86
Gdowski, A., Johnson, K. V. B., Shah, S., Gryczyński, I., Vishwanatha, J. K., & Ranjan, A. P. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0339-0 · Cited by 83
Arruebo, M., Usón, L., Miana, M. J., de Solorzano, I. O., Sebastián, V., & Larrea, A. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s108812 · Cited by 79
Gasparini, G., Kosvintsev, S. R., Stillwell, M. T., & Holdich, R. G. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.08.011 · Cited by 77
A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products
Troiano, G., Nolan, J., Parsons, D. M., Hoven, C. V. G., & Zale, S. E. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9969-z · Cited by 75
Nanosensors based on polymer vesicles and planar membranes: a short review
Idrissi, M. E., Meyer, C. E., Zartner, L., & Meier, W. P. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0393-7 · Cited by 73
Lee, Y., & Chang, D.-S. (2017) · Scientific Reports · doi:10.1038/srep46688 · Cited by 63
Preparation of Drug-Loaded PLGA-PEG Nanoparticles by Membrane-Assisted Nanoprecipitation
Albisa, A., Piacentini, E., Sebastián, V., Arruebo, M., Santamarı́a, J., & Giorno, L. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2146-y · Cited by 60
Sustainable Delivery Systems Through Green Nanotechnology
Krishnaswamy, K., & Orsat, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52727-9.00002-9 · Cited by 59
Min, K., Im, D. J., Lee, H., & Kim, D. (2014) · Lab on a Chip · doi:10.1039/c4lc00700j · Cited by 58
Zarchi, A. A. K., Abbasi, S., Faramarzi, M. A., Gilani, K., Ghazi‐Khansari, M., & Amani, A. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.09.004 · Cited by 55
McCarron, P. A., Donnelly, R. F., & Marouf, W. M. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600682390 · Cited by 53
Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles
Operti, M. C., Dölen, Y., Keulen, J., van Dinther, E. A. W., Figdor, C. G., & Tagit, O. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110590 · Cited by 53
Self-citationSolid/liquid separation equipment
Tarleton, E. S., & Wakeman, R. J. (2007) · Elsevier eBooks · doi:10.1016/b978-185617421-3/50001-8 · Cited by 52
Bohr, A., Boetker, J. P., Rades, T., Rantanen, J., & Yang, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990399 · Cited by 48
Besseling, R., Damen, M., Wijgergangs, J., Hermes, M., Wynia, G., & Gerich, A. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.03.024 · Cited by 48
Oral delivery of spray dried PLGA/amifostine nanoparticles
Pamujula, S., Graves, R. A., Freeman, T., Srinivasan, V., Bostanian, L. A., Kishore, V., & Mandal, T. K. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044210 · Cited by 47
Gangapurwala, G., Vollrath, A., Luis, A. D. S., & Schubert, U. S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111118 · Cited by 47
Operti, M. C., Fecher, D., van Dinther, E. A. W., Grimm, S., Jaber, R., Figdor, C. G., & Tagit, O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.044 · Cited by 46
Self-citationNanoscaled Dispersed Systems Used in Drug-Delivery Applications
Cheaburu-Yılmaz, C. N., Karasulu, H. Y., & Yılmaz, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00013-3 · Cited by 44
Dalvi, S. V., Azad, M. A., & Davé, R. N. (2012) · Powder Technology · doi:10.1016/j.powtec.2012.05.038 · Cited by 43
Kluge, J., Fusaro, F., Mazzotti, M., & Muhrer, G. (2009) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2009.05.002 · Cited by 40
Swider, E., Maharjan, S., Houkes, K. A., van Riessen, N. K., Figdor, C. G., Srinivas, M., & Tagit, O. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00754 · Cited by 38
Self-citationZidan, A. S., Rahman, Z., & Khan, M. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9184-2 · Cited by 37
Noncontact Infrared-Mediated Heat Transfer During Continuous Freeze-Drying of Unit Doses
Bockstal, P.-J. V., Meyer, L. D., Corver, J. A. W. M., Vervaet, C., & Beer, T. D. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.05.003 · Cited by 33
Zabihi, F., Xin, N., Jia, J., Chen, T., & Zhao, Y. (2014) · Industrial & Engineering Chemistry Research · doi:10.1021/ie404215h · Cited by 33
Bockstal, P.-J. V., Mortier, S. T. F. C., Meyer, L. D., Corver, J. A. W. M., Vervaet, C., Ingmar Nopens, A., & Beer, T. D. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.001 · Cited by 30
Best Practices for Optimization and Scale-Up of Microfiltration TFF Processes
Raghunath, B., Bin, W., Pattnaik, P., & Janssens, J. (2012) · BioProcessing Journal · doi:10.12665/j111.raghunath · Cited by 28
Tagit, O., de Ruiter, M. V., Brasch, M., Ma, Y., & Cornelissen, J. J. L. M. (2017) · RSC Advances · doi:10.1039/c7ra06684h · Cited by 28
Self-citationTukulula, M., Gouveia, L. F., Paixão, P. J. P. A., Hayeshi, R. K., Naicker, B., & Dube, A. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2391-8 · Cited by 28
Recent biomedical applications and patents on biodegradable polymer
Kaur, T., Kaur, R., & Kaur, A. (2014) · Cited by 27
Nepveux, K., Sherlock, J., Futran, M., Thien, M. P., & Krumme, M. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24286 · Cited by 26
Larrea, A., Clemente, A., Luque-Michel, E., & Sebastián, V. (2017) · Chemical Engineering Journal · doi:10.1016/j.cej.2017.02.003 · Cited by 26
Controlled-release of fluazinam from biodegradable PLGA-based microspheres
Wang, Q., Shen, M., Li, W., Li, W., & Zhang, F. (2019) · Journal of Environmental Science and Health Part B · doi:10.1080/03601234.2019.1634971 · Cited by 24
Downstream Process Design, Scale-Up Principles, and Process Modeling
Lacki, K. M., Joseph, J. R., & Eriksson, K. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100623-8.00032-3 · Cited by 21
Schiller, S., Hanefeld, A., Schneider, M., & Lehr, C. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1681-7 · Cited by 20
Zhang, X., Xu, Y., Zhang, W., Fu, X., Hao, Z., He, M., Trefilov, D., Ning, X., Ge, H., & Chen, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b21346 · Cited by 19
Sani, S. N., Das, N. G., & DAS, S. K. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802500655 · Cited by 18
Turino, L. N., Stella, B., Dosio, F., Luna, J. A., & Barresi, A. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1421662 · Cited by 18
Campardelli, R., & Reverchon, E. (2016) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2016.11.005 · Cited by 17
Medendorp, J., Bric, J., Connelly, G., Tolton, K., & Warman, M. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.04.019 · Cited by 16
Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine
Kubota, R., Fukumura, K., & Wajima, T. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2501-7 · Cited by 15
Tagit, O., Tomczak, N., Jafarpour, A., Jańczewski, D., Han, M., Vancso, G. J., & Herek, J. L. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/26/265701 · Cited by 11
Self-citationTagit, O., Annio, G., & Hildebrandt, N. (2015) · Microchimica Acta · doi:10.1007/s00604-015-1500-1 · Cited by 11
Self-citationPagels, R. F., & Prud’homme, R. K. (2017) · ACS symposium series · doi:10.1021/bk-2017-1271.ch011 · Cited by 7
EFFECT OF GAMMA-IRRADIATION ON BIODEGRADABLE MICROSPHERES LOADED WITH RASAGILINE MESYLATE
FERNÁNDEZ, M., Barcia, E., & Negro, S. (2016) · Journal of the Chilean Chemical Society · doi:10.4067/s0717-97072016000400005 · Cited by 5
Hu, T., Shi, F.-Y., Pan, L., Zhu, H., & Guo, L. (2014) · China Journal of Chinese Materia Medica · doi:10.4268/cjcmm20142321 · Cited by 1
Research works printed but not linked: 4
- Arnum, 2008, The Potential of Continuous Sterile Manufacturing, Pharm. Technol.
- Asandei, 2004, Preparation of drug delivery biodegradable nanocomposites by rapid expansion from supercritical solutions, Polymer Preprints, 45, 770
- Holzer, 2017, Is Continuous Downstream Processing Becoming a Reality, Bioprocess Int., 20
- Nagavarma, 2012, Different techniques for preparation of polymeric nanoparticles-a review, Asian J. Pharm. Clin. Res., 5, 16
Cited by
Sorted by citations
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A. K. S., Ruokolainen, J., & Kesari, K. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07840 · Cited by 367
Alsaab, H. O., Alharbi, F., Al-Hibs, A. S., Alanazi, N. B., Alshehri, B. Y., Saleh, M. A., Alshehri, F. S., Algarni, M. A., Almugaiteeb, T., Uddin, M. N., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122728 · Cited by 304
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Nunes, D., Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2022) · Polymers · doi:10.3390/polym14051010 · Cited by 144
Parvin, N., Aslam, M., Joo, S., & Mandal, T. K. (2025) · Molecules · doi:10.3390/molecules30153177 · Cited by 165
Metadata
- Authors
- Operti, M. C., Bernhardt, A., Grimm, S., Engel, A., Figdor, C. G., & Tagit, O.
- Affiliations
- Radboud University Nijmegen (NL)
- Corresponding author
- Tagit, Oya
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 605
- Pages
- 120807
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W3171433358
- Cited by
- 302
- References
- 134
- Citations by year
- 2026: 60 · 2025: 79 · 2024: 56 · 2023: 61 · 2022: 38 · 2021: 8
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- International Journal of Pharmaceutics (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- European Commission (HORIZON2020, 686089)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (269019)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Keywords
- PLGA nanoparticles, nanomedicine manufacturing, industrial scale-up, polymeric drug carriers, quality control, clinical translation, biodegradable polymers, drug delivery systems
- MeSH terms
- Industry, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review